Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 14,920
-230 (-1.52%)
At close: Sep 23, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 102.11 billion as of September 25, 2026. Its market cap has increased by 15.84% in one year.
Market Cap
102.11B
Enterprise Value
5.89B
Revenue
60.40B
Ranking
n/a
PE Ratio
6.08
Stock Price
14,920.00
ChartMarket Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 102.11B, an increase of 631.04%. That is a compound annual growth rate of 8.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 102.11B | 13.81% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 143.73B |
| TiumBio | 134.42B |
| Y-Biologics | 128.16B |
| ViGenCell | 117.26B |
| Prestige Biologics | 106.91B |
| AriBioLab | 98.47B |
| CORESTEMCHEMON | 91.83B |
| Choong Ang Vaccine Laboratory | 84.70B |